LYUMJEV sol inj 100 UI/ml p pen 5 amp 3 ml

7680677930010 CH-67793 A10AB04 07.06.1.
LYUMJEV sol inj 100 UI/ml p pen 5 amp 3 ml
LYUMJEV sol inj 100 UI/ml p pen 5 amp 3 ml
LYUMJEV sol inj 100 UI/ml p pen 5 amp 3 ml
1 / 3
google

Details

Product number
6779301
CPT
-
Packaging group
5 x 3
Unit
ml
Composition
insulinum lisprum 100 U.I., treprostinilum natricum, natrii citras dihydricus, zinci oxidum q.s., magnesii chloridum hexahydricum, metacresolum 3.15 mg, glycerolum, acidum hydrochloridum q.s., natrii hydroxidum q.s., aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.13 mg.

Articles (1)

Lyumjev cartouches 100 units/mL, solution injectable
Injektionslösung
5 x 3
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/05/2021
Patient information leaflet
Français
28/05/2021
Patient information leaflet
Italien
28/05/2021

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.15 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.13 MG Substance HBESI

Reimbursement information

Public price
CHF 53.75
Specialties list
Yes
Generic
No
SL addition date: 01/01/2021

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
67793
Drug name
Lyumjev cartouches, solution injectable
Galenic form
LSILP
ATC Code
A10AB04
Authorization status
Z
Dispensation category
B
First authorization
03/12/2020
Authorization expiration date
31/12/9999
IT number
07.06.1.
Domain
Human medicine

Packaging details

Description (FR)
LYUMJEV sol inj 100 UI/ml p pen 5 amp 3 ml
Description (DE)
LYUMJEV Inj Lös 100 IE/ml f Pen 5 Amp 3 ml
Market launch
03/12/2020
Narcotic (BTM)
No